

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 4.75767649 |
| 2 | central nervous system myelination (GO:0022010) | 4.75767649 |
| 3 | neuronal action potential propagation (GO:0019227) | 4.45805602 |
| 4 | L-amino acid import (GO:0043092) | 3.92104767 |
| 5 | presynaptic membrane assembly (GO:0097105) | 3.89343048 |
| 6 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.78283953 |
| 7 | presynaptic membrane organization (GO:0097090) | 3.70783042 |
| 8 | synaptic vesicle exocytosis (GO:0016079) | 3.66551624 |
| 9 | neuron cell-cell adhesion (GO:0007158) | 3.64783610 |
| 10 | gamma-aminobutyric acid transport (GO:0015812) | 3.63914098 |
| 11 | synaptic vesicle maturation (GO:0016188) | 3.59397954 |
| 12 | negative regulation of cell killing (GO:0031342) | 3.49625307 |
| 13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.49625307 |
| 14 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.49540987 |
| 15 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.47956419 |
| 16 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.47827743 |
| 17 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.43621090 |
| 18 | vocalization behavior (GO:0071625) | 3.41063731 |
| 19 | fatty acid elongation (GO:0030497) | 3.39850642 |
| 20 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.38342684 |
| 21 | glutamate secretion (GO:0014047) | 3.36832655 |
| 22 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.33193658 |
| 23 | locomotory exploration behavior (GO:0035641) | 3.32130830 |
| 24 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.27486325 |
| 25 | negative regulation of neurotransmitter transport (GO:0051589) | 3.26240439 |
| 26 | cellular ketone body metabolic process (GO:0046950) | 3.23360378 |
| 27 | amino acid import (GO:0043090) | 3.20928931 |
| 28 | protein localization to synapse (GO:0035418) | 3.20295475 |
| 29 | glutamate receptor signaling pathway (GO:0007215) | 3.13685721 |
| 30 | synaptic transmission, glutamatergic (GO:0035249) | 3.08116929 |
| 31 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.07707293 |
| 32 | negative regulation of protein oligomerization (GO:0032460) | 3.07198530 |
| 33 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.05566436 |
| 34 | regulation of synaptic vesicle transport (GO:1902803) | 3.05026507 |
| 35 | neuron-neuron synaptic transmission (GO:0007270) | 3.01548286 |
| 36 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.00017296 |
| 37 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.99735447 |
| 38 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.92610674 |
| 39 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.92445320 |
| 40 | cellular potassium ion homeostasis (GO:0030007) | 2.91716387 |
| 41 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.91689813 |
| 42 | transmission of nerve impulse (GO:0019226) | 2.89855569 |
| 43 | inositol phosphate catabolic process (GO:0071545) | 2.88629328 |
| 44 | postsynaptic membrane organization (GO:0001941) | 2.88552022 |
| 45 | ketone body metabolic process (GO:1902224) | 2.88347519 |
| 46 | regulation of glucokinase activity (GO:0033131) | 2.87910260 |
| 47 | regulation of hexokinase activity (GO:1903299) | 2.87910260 |
| 48 | neurotransmitter secretion (GO:0007269) | 2.83741015 |
| 49 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.83149917 |
| 50 | adult walking behavior (GO:0007628) | 2.82555871 |
| 51 | inositol phosphate dephosphorylation (GO:0046855) | 2.82413726 |
| 52 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.82413726 |
| 53 | neuromuscular process controlling posture (GO:0050884) | 2.81857597 |
| 54 | platelet dense granule organization (GO:0060155) | 2.81015298 |
| 55 | long-term memory (GO:0007616) | 2.79955972 |
| 56 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.79216655 |
| 57 | positive regulation of membrane potential (GO:0045838) | 2.77601379 |
| 58 | positive regulation of glycolytic process (GO:0045821) | 2.74883292 |
| 59 | acidic amino acid transport (GO:0015800) | 2.74179581 |
| 60 | regulation of beta-amyloid formation (GO:1902003) | 2.73710608 |
| 61 | long-term synaptic potentiation (GO:0060291) | 2.73080488 |
| 62 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.72034682 |
| 63 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.70853503 |
| 64 | neurotransmitter uptake (GO:0001504) | 2.69942627 |
| 65 | glycine transport (GO:0015816) | 2.69274592 |
| 66 | myelination (GO:0042552) | 2.67191055 |
| 67 | neurotransmitter transport (GO:0006836) | 2.64865055 |
| 68 | regulation of protein glycosylation (GO:0060049) | 2.63616559 |
| 69 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.63505954 |
| 70 | ensheathment of neurons (GO:0007272) | 2.62088341 |
| 71 | axon ensheathment (GO:0008366) | 2.62088341 |
| 72 | cerebellar granule cell differentiation (GO:0021707) | 2.60630754 |
| 73 | response to methylmercury (GO:0051597) | 2.58838431 |
| 74 | response to auditory stimulus (GO:0010996) | 2.58815400 |
| 75 | L-glutamate transport (GO:0015813) | 2.58577086 |
| 76 | endocrine pancreas development (GO:0031018) | 2.57190507 |
| 77 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.56635542 |
| 78 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.55143885 |
| 79 | negative regulation of complement activation (GO:0045916) | 2.54234589 |
| 80 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.52821943 |
| 81 | adaptation of signaling pathway (GO:0023058) | 2.51740981 |
| 82 | regulation of postsynaptic membrane potential (GO:0060078) | 2.51299538 |
| 83 | exploration behavior (GO:0035640) | 2.50527714 |
| 84 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.49431813 |
| 85 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.49364018 |
| 86 | microglial cell activation (GO:0001774) | 2.48743355 |
| 87 | regulation of neurotransmitter secretion (GO:0046928) | 2.48131854 |
| 88 | protein targeting to Golgi (GO:0000042) | 2.48039044 |
| 89 | positive regulation of insulin secretion (GO:0032024) | 2.47441117 |
| 90 | potassium ion import (GO:0010107) | 2.46311034 |
| 91 | cellular response to ethanol (GO:0071361) | 2.45489721 |
| 92 | neutrophil activation involved in immune response (GO:0002283) | 2.45126063 |
| 93 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.44689660 |
| 94 | L-phenylalanine catabolic process (GO:0006559) | 2.44351786 |
| 95 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.44351786 |
| 96 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.44077816 |
| 97 | regulation of neurotransmitter levels (GO:0001505) | 2.43810276 |
| 98 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.43365750 |
| 99 | auditory behavior (GO:0031223) | 2.41806137 |
| 100 | detection of calcium ion (GO:0005513) | 2.41780134 |
| 101 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.40484609 |
| 102 | regulation of synaptic plasticity (GO:0048167) | 2.40315138 |
| 103 | polyol catabolic process (GO:0046174) | 2.40280471 |
| 104 | negative regulation of protein localization to cell surface (GO:2000009) | 2.40180882 |
| 105 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.39922614 |
| 106 | macrophage activation involved in immune response (GO:0002281) | 2.39510062 |
| 107 | behavioral response to cocaine (GO:0048148) | 2.38993944 |
| 108 | oligodendrocyte differentiation (GO:0048709) | 2.37895301 |
| 109 | import into cell (GO:0098657) | 2.37810265 |
| 110 | xenobiotic catabolic process (GO:0042178) | 2.37666376 |
| 111 | negative regulation of protein activation cascade (GO:2000258) | 2.37563859 |
| 112 | regulation of neurotransmitter transport (GO:0051588) | 2.36752897 |
| 113 | neuron recognition (GO:0008038) | 2.35690024 |
| 114 | insulin secretion (GO:0030073) | 2.35435134 |
| 115 | mechanosensory behavior (GO:0007638) | 2.31874048 |
| 116 | negative regulation of synaptic transmission (GO:0050805) | 2.31365783 |
| 117 | signal peptide processing (GO:0006465) | 2.30532530 |
| 118 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.30110074 |
| 119 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.30092279 |
| 120 | phospholipid homeostasis (GO:0055091) | 2.29579540 |
| 121 | regulation of glutamate secretion (GO:0014048) | 2.28999828 |
| 122 | startle response (GO:0001964) | 2.28842400 |
| 123 | neuronal ion channel clustering (GO:0045161) | 2.28154462 |
| 124 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.28141273 |
| 125 | dendritic spine morphogenesis (GO:0060997) | 2.27444639 |
| 126 | positive regulation of peptide hormone secretion (GO:0090277) | 2.27343404 |
| 127 | negative regulation of humoral immune response (GO:0002921) | 2.27223031 |
| 128 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.27196046 |
| 129 | membrane hyperpolarization (GO:0060081) | 2.27039209 |
| 130 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.26703386 |
| 131 | glycerophospholipid catabolic process (GO:0046475) | 2.26445235 |
| 132 | establishment of protein localization to Golgi (GO:0072600) | 2.25846527 |
| 133 | regulation of cellular amide metabolic process (GO:0034248) | 2.24880626 |
| 134 | macroautophagy (GO:0016236) | 2.24732046 |
| 135 | membrane depolarization (GO:0051899) | 2.24708516 |
| 136 | C4-dicarboxylate transport (GO:0015740) | 2.23703625 |
| 137 | regulation of vesicle fusion (GO:0031338) | 2.23546402 |
| 138 | epithelial cilium movement (GO:0003351) | 2.23095533 |
| 139 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.22900473 |
| 140 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.22880221 |
| 141 | brain morphogenesis (GO:0048854) | 2.22726263 |
| 142 | learning (GO:0007612) | 2.21326031 |
| 143 | positive regulation of peptide secretion (GO:0002793) | 2.20988717 |
| 144 | regulation of memory T cell differentiation (GO:0043380) | 2.20109209 |
| 145 | regulation of synapse structural plasticity (GO:0051823) | 2.19808291 |
| 146 | mating behavior (GO:0007617) | 2.19289408 |
| 147 | nitric oxide mediated signal transduction (GO:0007263) | 2.18230119 |
| 148 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.17320108 |
| 149 | adult locomotory behavior (GO:0008344) | 2.17133973 |
| 150 | heme transport (GO:0015886) | 2.16582576 |
| 151 | L-fucose catabolic process (GO:0042355) | 2.16168283 |
| 152 | fucose catabolic process (GO:0019317) | 2.16168283 |
| 153 | L-fucose metabolic process (GO:0042354) | 2.16168283 |
| 154 | reverse cholesterol transport (GO:0043691) | 2.16093706 |
| 155 | retinal cone cell development (GO:0046549) | 2.15672746 |
| 156 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.12486958 |
| 157 | L-phenylalanine metabolic process (GO:0006558) | 2.12486958 |
| 158 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.11660597 |
| 159 | phagosome maturation (GO:0090382) | 2.11150808 |
| 160 | cellular response to interleukin-15 (GO:0071350) | 2.11128129 |
| 161 | ferric iron transport (GO:0015682) | 2.10642091 |
| 162 | trivalent inorganic cation transport (GO:0072512) | 2.10642091 |
| 163 | macrophage activation (GO:0042116) | 2.09317120 |
| 164 | negative regulation of protein autophosphorylation (GO:0031953) | 2.08515892 |
| 165 | peroxisome organization (GO:0007031) | 2.08275845 |
| 166 | axoneme assembly (GO:0035082) | 2.07624614 |
| 167 | protein localization to cilium (GO:0061512) | 2.07268967 |
| 168 | transcytosis (GO:0045056) | 2.06304804 |
| 169 | nucleotide transmembrane transport (GO:1901679) | 2.06245371 |
| 170 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 2.05997544 |
| 171 | regulation of triglyceride catabolic process (GO:0010896) | 2.03302954 |
| 172 | transferrin transport (GO:0033572) | 2.01662284 |
| 173 | negative regulation of neurological system process (GO:0031645) | 2.01028746 |
| 174 | sequestering of metal ion (GO:0051238) | 2.00244095 |
| 175 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 1.99741594 |
| 176 | dopamine transport (GO:0015872) | 1.99184227 |
| 177 | neutrophil activation (GO:0042119) | 1.98695343 |
| 178 | negative regulation of execution phase of apoptosis (GO:1900118) | 1.98564975 |
| 179 | cilium movement (GO:0003341) | 1.98354750 |
| 180 | regulation of insulin secretion (GO:0050796) | 1.96790487 |
| 181 | cilium or flagellum-dependent cell motility (GO:0001539) | 1.96119946 |
| 182 | transepithelial transport (GO:0070633) | 1.95884987 |
| 183 | protein localization to Golgi apparatus (GO:0034067) | 1.95451440 |
| 184 | peptide hormone processing (GO:0016486) | 1.94496216 |
| 185 | epoxygenase P450 pathway (GO:0019373) | 1.94248116 |
| 186 | proline transport (GO:0015824) | 1.94183066 |
| 187 | high-density lipoprotein particle remodeling (GO:0034375) | 1.93626173 |
| 188 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 1.91670548 |
| 189 | peroxisome fission (GO:0016559) | 1.91669070 |
| 190 | lactate metabolic process (GO:0006089) | 1.90784375 |
| 191 | regulation of mononuclear cell migration (GO:0071675) | 1.90205213 |
| 192 | regulation of regulatory T cell differentiation (GO:0045589) | 1.90015433 |
| 193 | regulation of vacuole organization (GO:0044088) | 1.89195638 |
| 194 | positive regulation of respiratory burst (GO:0060267) | 1.89002515 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.24299163 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.62598541 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.69965288 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.64155346 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.61405775 |
| 6 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.59542160 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.46041655 |
| 8 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.23509422 |
| 9 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.21030631 |
| 10 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.16225416 |
| 11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.15477763 |
| 12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.15477763 |
| 13 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.15452360 |
| 14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.15353559 |
| 15 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.07709418 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.05645919 |
| 17 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.05055720 |
| 18 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.00851976 |
| 19 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.94344146 |
| 20 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.93293931 |
| 21 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.90091184 |
| 22 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.85161310 |
| 23 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.84386804 |
| 24 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.82727357 |
| 25 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.82288913 |
| 26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.82262103 |
| 27 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.81206692 |
| 28 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.79422852 |
| 29 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.75790696 |
| 30 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.69993869 |
| 31 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.67031463 |
| 32 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.61538268 |
| 33 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.61450181 |
| 34 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.59683165 |
| 35 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.58813839 |
| 36 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.53151063 |
| 37 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.49140296 |
| 38 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.48537041 |
| 39 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.48466692 |
| 40 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.48319235 |
| 41 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.48286195 |
| 42 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.48139291 |
| 43 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.46608228 |
| 44 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.44410770 |
| 45 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.42503247 |
| 46 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.41496263 |
| 47 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.41471685 |
| 48 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.41284422 |
| 49 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.40991452 |
| 50 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.39052956 |
| 51 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.38360800 |
| 52 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.35477979 |
| 53 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34758726 |
| 54 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.34135113 |
| 55 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.33766816 |
| 56 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.31464911 |
| 57 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.30127784 |
| 58 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.28593021 |
| 59 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.25842717 |
| 60 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.24274440 |
| 61 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.24274440 |
| 62 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.24235281 |
| 63 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.24207463 |
| 64 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.23482863 |
| 65 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.22465587 |
| 66 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.22260293 |
| 67 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.21766812 |
| 68 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.21361870 |
| 69 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.21291602 |
| 70 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.20960309 |
| 71 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.19595439 |
| 72 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.19351240 |
| 73 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.19351240 |
| 74 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.17569566 |
| 75 | STAT3_23295773_ChIP-Seq_U87_Human | 1.17502917 |
| 76 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.17032315 |
| 77 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.16947988 |
| 78 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.15381174 |
| 79 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.14671159 |
| 80 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.14159557 |
| 81 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.13724578 |
| 82 | VDR_22108803_ChIP-Seq_LS180_Human | 1.13415795 |
| 83 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.12860059 |
| 84 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.11727026 |
| 85 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.11457740 |
| 86 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.10739106 |
| 87 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.10489626 |
| 88 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.10370325 |
| 89 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.10370325 |
| 90 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.09732064 |
| 91 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.09378538 |
| 92 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.08793464 |
| 93 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.07527725 |
| 94 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.07199484 |
| 95 | * RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.06386092 |
| 96 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.05915510 |
| 97 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.05874026 |
| 98 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.05505158 |
| 99 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.04549186 |
| 100 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04053387 |
| 101 | * PU1_27457419_Chip-Seq_LIVER_Mouse | 1.03876266 |
| 102 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.03809220 |
| 103 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.03093423 |
| 104 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.02287231 |
| 105 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.02047606 |
| 106 | TCF4_23295773_ChIP-Seq_U87_Human | 1.02036176 |
| 107 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01723614 |
| 108 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.01011532 |
| 109 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.00775680 |
| 110 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.00564643 |
| 111 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.00545599 |
| 112 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.00452700 |
| 113 | * CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.00294751 |
| 114 | EWS_26573619_Chip-Seq_HEK293_Human | 0.99863711 |
| 115 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.99418745 |
| 116 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.99128357 |
| 117 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.98804125 |
| 118 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.98749373 |
| 119 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.98335892 |
| 120 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.96866287 |
| 121 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96530518 |
| 122 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.95920235 |
| 123 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.95901023 |
| 124 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.94684194 |
| 125 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.94677005 |
| 126 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.93418713 |
| 127 | * P300_18555785_Chip-Seq_ESCs_Mouse | 0.93165568 |
| 128 | * KDM2B_26808549_Chip-Seq_REH_Human | 0.92174432 |
| 129 | * RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.92057605 |
| 130 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.92036828 |
| 131 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.92005424 |
| 132 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.91706511 |
| 133 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.91556074 |
| 134 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.91311905 |
| 135 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.90290953 |
| 136 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.89991652 |
| 137 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.88999577 |
| 138 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.88062519 |
| 139 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.87669320 |
| 140 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.87423360 |
| 141 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.87123952 |
| 142 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.86158633 |
| 143 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.85779939 |
| 144 | TP53_16413492_ChIP-PET_HCT116_Human | 0.85658575 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.33827022 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.26966140 |
| 3 | MP0004270_analgesia | 3.23344696 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.12262579 |
| 5 | MP0010234_abnormal_vibrissa_follicle | 3.08232760 |
| 6 | MP0009046_muscle_twitch | 3.06349592 |
| 7 | MP0002064_seizures | 2.97158910 |
| 8 | MP0009745_abnormal_behavioral_response | 2.87541975 |
| 9 | MP0006082_CNS_inflammation | 2.81915577 |
| 10 | MP0003724_increased_susceptibility_to | 2.81681967 |
| 11 | MP0002272_abnormal_nervous_system | 2.61069360 |
| 12 | MP0001486_abnormal_startle_reflex | 2.58019176 |
| 13 | MP0000920_abnormal_myelination | 2.54394187 |
| 14 | MP0003690_abnormal_glial_cell | 2.38806873 |
| 15 | MP0001968_abnormal_touch/_nociception | 2.38418278 |
| 16 | MP0002063_abnormal_learning/memory/cond | 2.37122406 |
| 17 | MP0000569_abnormal_digit_pigmentation | 2.34686589 |
| 18 | MP0003329_amyloid_beta_deposits | 2.26543894 |
| 19 | MP0005365_abnormal_bile_salt | 2.26508146 |
| 20 | MP0002572_abnormal_emotion/affect_behav | 2.24736859 |
| 21 | MP0002254_reproductive_system_inflammat | 2.22935628 |
| 22 | MP0002734_abnormal_mechanical_nocicepti | 2.14631016 |
| 23 | MP0005423_abnormal_somatic_nervous | 2.10066443 |
| 24 | MP0002837_dystrophic_cardiac_calcinosis | 2.05077819 |
| 25 | MP0002822_catalepsy | 2.03569806 |
| 26 | MP0001501_abnormal_sleep_pattern | 2.02824778 |
| 27 | MP0002736_abnormal_nociception_after | 1.90570391 |
| 28 | MP0004885_abnormal_endolymph | 1.90543269 |
| 29 | MP0002067_abnormal_sensory_capabilities | 1.85111034 |
| 30 | MP0004142_abnormal_muscle_tone | 1.84818929 |
| 31 | MP0001440_abnormal_grooming_behavior | 1.82163103 |
| 32 | MP0003300_gastrointestinal_ulcer | 1.78467643 |
| 33 | MP0003787_abnormal_imprinting | 1.78185740 |
| 34 | MP0008569_lethality_at_weaning | 1.76401297 |
| 35 | MP0005379_endocrine/exocrine_gland_phen | 1.74348370 |
| 36 | MP0002735_abnormal_chemical_nociception | 1.71743918 |
| 37 | MP0009785_altered_susceptibility_to | 1.67819777 |
| 38 | MP0001970_abnormal_pain_threshold | 1.67032739 |
| 39 | MP0005671_abnormal_response_to | 1.66347446 |
| 40 | MP0003136_yellow_coat_color | 1.66265244 |
| 41 | MP0005171_absent_coat_pigmentation | 1.65652607 |
| 42 | MP0003633_abnormal_nervous_system | 1.64057943 |
| 43 | MP0001905_abnormal_dopamine_level | 1.62733139 |
| 44 | MP0000604_amyloidosis | 1.55161585 |
| 45 | MP0004019_abnormal_vitamin_homeostasis | 1.54200281 |
| 46 | MP0004742_abnormal_vestibular_system | 1.53496328 |
| 47 | MP0002733_abnormal_thermal_nociception | 1.53453044 |
| 48 | MP0005646_abnormal_pituitary_gland | 1.52535880 |
| 49 | MP0010329_abnormal_lipoprotein_level | 1.52081957 |
| 50 | MP0003195_calcinosis | 1.48570469 |
| 51 | MP0002693_abnormal_pancreas_physiology | 1.44009278 |
| 52 | MP0004043_abnormal_pH_regulation | 1.42980990 |
| 53 | MP0003252_abnormal_bile_duct | 1.41423935 |
| 54 | MP0003634_abnormal_glial_cell | 1.41168007 |
| 55 | MP0005551_abnormal_eye_electrophysiolog | 1.40576304 |
| 56 | MP0001984_abnormal_olfaction | 1.40433785 |
| 57 | MP0003631_nervous_system_phenotype | 1.38634606 |
| 58 | MP0002876_abnormal_thyroid_physiology | 1.37948736 |
| 59 | MP0002229_neurodegeneration | 1.37820140 |
| 60 | MP0009780_abnormal_chondrocyte_physiolo | 1.35694057 |
| 61 | MP0008877_abnormal_DNA_methylation | 1.35072964 |
| 62 | MP0004924_abnormal_behavior | 1.34490621 |
| 63 | MP0005386_behavior/neurological_phenoty | 1.34490621 |
| 64 | MP0003122_maternal_imprinting | 1.33048654 |
| 65 | MP0005409_darkened_coat_color | 1.31368410 |
| 66 | MP0003075_altered_response_to | 1.31005227 |
| 67 | MP0000778_abnormal_nervous_system | 1.29589751 |
| 68 | MP0001502_abnormal_circadian_rhythm | 1.29263935 |
| 69 | MP0002557_abnormal_social/conspecific_i | 1.28853262 |
| 70 | MP0001756_abnormal_urination | 1.28299445 |
| 71 | MP0002138_abnormal_hepatobiliary_system | 1.28192853 |
| 72 | MP0002277_abnormal_respiratory_mucosa | 1.27852943 |
| 73 | MP0003045_fibrosis | 1.27823543 |
| 74 | MP0006072_abnormal_retinal_apoptosis | 1.26982474 |
| 75 | MP0008260_abnormal_autophagy | 1.26105134 |
| 76 | MP0002066_abnormal_motor_capabilities/c | 1.24727888 |
| 77 | MP0001790_abnormal_immune_system | 1.23608557 |
| 78 | MP0005387_immune_system_phenotype | 1.23608557 |
| 79 | MP0001529_abnormal_vocalization | 1.23077056 |
| 80 | MP0001666_abnormal_nutrient_absorption | 1.23019780 |
| 81 | MP0003868_abnormal_feces_composition | 1.21819454 |
| 82 | MP0005645_abnormal_hypothalamus_physiol | 1.19430837 |
| 83 | MP0004858_abnormal_nervous_system | 1.19212970 |
| 84 | MP0003879_abnormal_hair_cell | 1.15881170 |
| 85 | MP0006054_spinal_hemorrhage | 1.14427716 |
| 86 | MP0003632_abnormal_nervous_system | 1.14274104 |
| 87 | MP0002882_abnormal_neuron_morphology | 1.14209741 |
| 88 | MP0002139_abnormal_hepatobiliary_system | 1.12949489 |
| 89 | MP0005310_abnormal_salivary_gland | 1.12005191 |
| 90 | MP0006276_abnormal_autonomic_nervous | 1.11947234 |
| 91 | MP0005058_abnormal_lysosome_morphology | 1.10661160 |
| 92 | MP0001188_hyperpigmentation | 1.10575002 |
| 93 | MP0000955_abnormal_spinal_cord | 1.10386104 |
| 94 | MP0005174_abnormal_tail_pigmentation | 1.10121165 |
| 95 | MP0005636_abnormal_mineral_homeostasis | 1.09730667 |
| 96 | MP0001835_abnormal_antigen_presentation | 1.09014146 |
| 97 | MP0000465_gastrointestinal_hemorrhage | 1.08866499 |
| 98 | MP0002078_abnormal_glucose_homeostasis | 1.08722727 |
| 99 | MP0001944_abnormal_pancreas_morphology | 1.06923986 |
| 100 | MP0002184_abnormal_innervation | 1.01749622 |
| 101 | MP0001963_abnormal_hearing_physiology | 1.01321566 |
| 102 | MP0010678_abnormal_skin_adnexa | 1.00076613 |
| 103 | MP0002419_abnormal_innate_immunity | 0.99952726 |
| 104 | MP0002148_abnormal_hypersensitivity_rea | 0.99081911 |
| 105 | MP0003183_abnormal_peptide_metabolism | 0.98894143 |
| 106 | MP0005000_abnormal_immune_tolerance | 0.98358613 |
| 107 | MP0000013_abnormal_adipose_tissue | 0.97595520 |
| 108 | MP0005025_abnormal_response_to | 0.97496159 |
| 109 | MP0001177_atelectasis | 0.97277429 |
| 110 | MP0002090_abnormal_vision | 0.97215814 |
| 111 | MP0005535_abnormal_body_temperature | 0.96303978 |
| 112 | MP0001485_abnormal_pinna_reflex | 0.94500941 |
| 113 | MP0004811_abnormal_neuron_physiology | 0.93275357 |
| 114 | MP0002928_abnormal_bile_duct | 0.92926128 |
| 115 | MP0005084_abnormal_gallbladder_morpholo | 0.92719347 |
| 116 | MP0001845_abnormal_inflammatory_respons | 0.92186292 |
| 117 | MP0008875_abnormal_xenobiotic_pharmacok | 0.90754100 |
| 118 | MP0001986_abnormal_taste_sensitivity | 0.89133436 |
| 119 | MP0003283_abnormal_digestive_organ | 0.88777853 |
| 120 | MP0002909_abnormal_adrenal_gland | 0.88620274 |
| 121 | MP0001800_abnormal_humoral_immune | 0.87246500 |
| 122 | MP0008874_decreased_physiological_sensi | 0.86864871 |
| 123 | MP0005167_abnormal_blood-brain_barrier | 0.86601056 |
| 124 | MP0005464_abnormal_platelet_physiology | 0.86537511 |
| 125 | MP0002723_abnormal_immune_serum | 0.85226425 |
| 126 | MP0001764_abnormal_homeostasis | 0.84959727 |
| 127 | MP0004484_altered_response_of | 0.84610704 |
| 128 | MP0003866_abnormal_defecation | 0.84363997 |
| 129 | MP0008469_abnormal_protein_level | 0.82352995 |
| 130 | MP0004215_abnormal_myocardial_fiber | 0.81566471 |
| 131 | MP0005332_abnormal_amino_acid | 0.80638800 |
| 132 | MP0002132_abnormal_respiratory_system | 0.79247083 |
| 133 | MP0004147_increased_porphyrin_level | 0.79161573 |
| 134 | MP0004381_abnormal_hair_follicle | 0.73870774 |
| 135 | MP0010386_abnormal_urinary_bladder | 0.73686233 |
| 136 | MP0005360_urolithiasis | 0.73657638 |
| 137 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.72985423 |
| 138 | MP0005410_abnormal_fertilization | 0.71719558 |
| 139 | MP0003011_delayed_dark_adaptation | 0.71432379 |
| 140 | MP0005085_abnormal_gallbladder_physiolo | 0.70098628 |
| 141 | MP0002069_abnormal_eating/drinking_beha | 0.69324829 |
| 142 | MP0002752_abnormal_somatic_nervous | 0.68696666 |
| 143 | MP0004145_abnormal_muscle_electrophysio | 0.68473039 |
| 144 | MP0003172_abnormal_lysosome_physiology | 0.67632680 |
| 145 | MP0001664_abnormal_digestion | 0.66844423 |
| 146 | MP0002638_abnormal_pupillary_reflex | 0.65588209 |
| 147 | MP0002118_abnormal_lipid_homeostasis | 0.63726329 |
| 148 | MP0005595_abnormal_vascular_smooth | 0.63465456 |
| 149 | MP0005253_abnormal_eye_physiology | 0.62846311 |
| 150 | MP0008872_abnormal_physiological_respon | 0.62788524 |
| 151 | MP0002152_abnormal_brain_morphology | 0.60318240 |
| 152 | MP0000372_irregular_coat_pigmentation | 0.60214425 |
| 153 | MP0005166_decreased_susceptibility_to | 0.59095856 |
| 154 | MP0001765_abnormal_ion_homeostasis | 0.58345845 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.17438332 |
| 2 | Neurofibrillary tangles (HP:0002185) | 4.54662859 |
| 3 | Myokymia (HP:0002411) | 4.47736786 |
| 4 | Hypoglycemic seizures (HP:0002173) | 3.86918464 |
| 5 | Focal seizures (HP:0007359) | 3.85211409 |
| 6 | Atonic seizures (HP:0010819) | 3.80993295 |
| 7 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.79634202 |
| 8 | Hypoglycemic coma (HP:0001325) | 3.76300829 |
| 9 | Epileptic encephalopathy (HP:0200134) | 3.63195001 |
| 10 | Progressive cerebellar ataxia (HP:0002073) | 3.63163269 |
| 11 | Supranuclear gaze palsy (HP:0000605) | 3.53029011 |
| 12 | Action tremor (HP:0002345) | 3.44309721 |
| 13 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.27536989 |
| 14 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.27536989 |
| 15 | Febrile seizures (HP:0002373) | 3.26386242 |
| 16 | Cerebral inclusion bodies (HP:0100314) | 3.24258307 |
| 17 | Dysmetria (HP:0001310) | 3.22681632 |
| 18 | Hyperventilation (HP:0002883) | 3.21033347 |
| 19 | Scanning speech (HP:0002168) | 3.14829117 |
| 20 | Ketoacidosis (HP:0001993) | 3.10727710 |
| 21 | Dialeptic seizures (HP:0011146) | 3.05026141 |
| 22 | Absence seizures (HP:0002121) | 3.04900880 |
| 23 | Intention tremor (HP:0002080) | 2.93727859 |
| 24 | Generalized tonic-clonic seizures (HP:0002069) | 2.92972845 |
| 25 | Gaze-evoked nystagmus (HP:0000640) | 2.88599621 |
| 26 | Abnormality of the corticospinal tract (HP:0002492) | 2.83894768 |
| 27 | Hypothermia (HP:0002045) | 2.78511202 |
| 28 | Visual hallucinations (HP:0002367) | 2.76114489 |
| 29 | Broad-based gait (HP:0002136) | 2.75852721 |
| 30 | Large for gestational age (HP:0001520) | 2.72185974 |
| 31 | Abnormality of binocular vision (HP:0011514) | 2.69792262 |
| 32 | Diplopia (HP:0000651) | 2.69792262 |
| 33 | Symptomatic seizures (HP:0011145) | 2.67707846 |
| 34 | Peripheral hypomyelination (HP:0007182) | 2.63640283 |
| 35 | Abnormal eating behavior (HP:0100738) | 2.61244641 |
| 36 | Hyperglycemia (HP:0003074) | 2.59548316 |
| 37 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.58498428 |
| 38 | Dysdiadochokinesis (HP:0002075) | 2.58174789 |
| 39 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.56689432 |
| 40 | Spastic gait (HP:0002064) | 2.54254050 |
| 41 | Anxiety (HP:0000739) | 2.53422808 |
| 42 | Increased CSF protein (HP:0002922) | 2.52804992 |
| 43 | Slow saccadic eye movements (HP:0000514) | 2.52417079 |
| 44 | Blue irides (HP:0000635) | 2.52266064 |
| 45 | Ankle clonus (HP:0011448) | 2.49294873 |
| 46 | Hemiparesis (HP:0001269) | 2.45376635 |
| 47 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.43359732 |
| 48 | Pheochromocytoma (HP:0002666) | 2.40272327 |
| 49 | Parakeratosis (HP:0001036) | 2.38539577 |
| 50 | Truncal ataxia (HP:0002078) | 2.35084207 |
| 51 | Onion bulb formation (HP:0003383) | 2.34933222 |
| 52 | Metabolic alkalosis (HP:0200114) | 2.33335981 |
| 53 | Increased circulating renin level (HP:0000848) | 2.32417232 |
| 54 | Thyroiditis (HP:0100646) | 2.30065659 |
| 55 | Ketosis (HP:0001946) | 2.29830195 |
| 56 | Vacuolated lymphocytes (HP:0001922) | 2.29239199 |
| 57 | Amyloidosis (HP:0011034) | 2.28264958 |
| 58 | Progressive inability to walk (HP:0002505) | 2.26765719 |
| 59 | Abnormality of macrophages (HP:0004311) | 2.25509115 |
| 60 | Generalized myoclonic seizures (HP:0002123) | 2.25352939 |
| 61 | Depression (HP:0000716) | 2.23879796 |
| 62 | Postural instability (HP:0002172) | 2.23281619 |
| 63 | Hematochezia (HP:0002573) | 2.22587649 |
| 64 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.22475476 |
| 65 | Insidious onset (HP:0003587) | 2.22419173 |
| 66 | Termporal pattern (HP:0011008) | 2.22419173 |
| 67 | Steatorrhea (HP:0002570) | 2.22250493 |
| 68 | Clumsiness (HP:0002312) | 2.21144615 |
| 69 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.20280477 |
| 70 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.20280477 |
| 71 | Retinal dysplasia (HP:0007973) | 2.19809463 |
| 72 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.19653294 |
| 73 | Megalencephaly (HP:0001355) | 2.18101187 |
| 74 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.16947360 |
| 75 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.14284420 |
| 76 | Neuroendocrine neoplasm (HP:0100634) | 2.14190952 |
| 77 | Sensory axonal neuropathy (HP:0003390) | 2.13418526 |
| 78 | Mutism (HP:0002300) | 2.12420396 |
| 79 | Renal cortical cysts (HP:0000803) | 2.12207556 |
| 80 | Abnormality of saccadic eye movements (HP:0000570) | 2.11820791 |
| 81 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.11775724 |
| 82 | Hemiplegia (HP:0002301) | 2.08908802 |
| 83 | Status epilepticus (HP:0002133) | 2.08257559 |
| 84 | Genetic anticipation (HP:0003743) | 2.07301052 |
| 85 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.06614504 |
| 86 | Neuronal loss in central nervous system (HP:0002529) | 2.01405938 |
| 87 | Fat malabsorption (HP:0002630) | 2.01279301 |
| 88 | Hypoproteinemia (HP:0003075) | 2.01177362 |
| 89 | Cerebral hemorrhage (HP:0001342) | 2.00655246 |
| 90 | Prolonged partial thromboplastin time (HP:0003645) | 1.99215614 |
| 91 | Poor eye contact (HP:0000817) | 1.99177690 |
| 92 | Hyperlipoproteinemia (HP:0010980) | 1.98738346 |
| 93 | Polyphagia (HP:0002591) | 1.97763695 |
| 94 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.97304372 |
| 95 | Aplasia of the phalanges of the hand (HP:0009802) | 1.97304372 |
| 96 | Aplasia involving bones of the extremities (HP:0009825) | 1.97304372 |
| 97 | Lower limb muscle weakness (HP:0007340) | 1.97072368 |
| 98 | Glomerulonephritis (HP:0000099) | 1.96458239 |
| 99 | Eczematoid dermatitis (HP:0000976) | 1.96235726 |
| 100 | Akinesia (HP:0002304) | 1.95838038 |
| 101 | Recurrent bacterial skin infections (HP:0005406) | 1.95761856 |
| 102 | Abnormality of the renal cortex (HP:0011035) | 1.94612516 |
| 103 | Split foot (HP:0001839) | 1.94587971 |
| 104 | Potter facies (HP:0002009) | 1.94565151 |
| 105 | Facial shape deformation (HP:0011334) | 1.94565151 |
| 106 | Systemic lupus erythematosus (HP:0002725) | 1.93345170 |
| 107 | Axonal loss (HP:0003447) | 1.91785201 |
| 108 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.91207309 |
| 109 | Episodic fever (HP:0001954) | 1.90912483 |
| 110 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.90106375 |
| 111 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.90106375 |
| 112 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.90106375 |
| 113 | Ventricular fibrillation (HP:0001663) | 1.89833826 |
| 114 | Torticollis (HP:0000473) | 1.89136226 |
| 115 | Medial flaring of the eyebrow (HP:0010747) | 1.88160085 |
| 116 | Abnormal ciliary motility (HP:0012262) | 1.86988352 |
| 117 | Optic neuritis (HP:0100653) | 1.86775329 |
| 118 | Retrobulbar optic neuritis (HP:0100654) | 1.86775329 |
| 119 | Abnormality of urine glucose concentration (HP:0011016) | 1.86743933 |
| 120 | Glycosuria (HP:0003076) | 1.86743933 |
| 121 | Hypomagnesemia (HP:0002917) | 1.86036575 |
| 122 | Hypokalemic alkalosis (HP:0001949) | 1.85831809 |
| 123 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.85735443 |
| 124 | Mucopolysacchariduria (HP:0008155) | 1.85735443 |
| 125 | Progressive neurologic deterioration (HP:0002344) | 1.85296967 |
| 126 | Psychosis (HP:0000709) | 1.85247681 |
| 127 | * Stomatitis (HP:0010280) | 1.84204655 |
| 128 | Postural tremor (HP:0002174) | 1.83392728 |
| 129 | Impaired social interactions (HP:0000735) | 1.83216521 |
| 130 | Abnormal social behavior (HP:0012433) | 1.83216521 |
| 131 | Agitation (HP:0000713) | 1.82819913 |
| 132 | Chronic diarrhea (HP:0002028) | 1.82757428 |
| 133 | Thickened helices (HP:0000391) | 1.82261566 |
| 134 | Spastic tetraparesis (HP:0001285) | 1.81977499 |
| 135 | Rigidity (HP:0002063) | 1.81008991 |
| 136 | Tongue fasciculations (HP:0001308) | 1.80574714 |
| 137 | Conjunctival hamartoma (HP:0100780) | 1.80409621 |
| 138 | Excessive salivation (HP:0003781) | 1.80212011 |
| 139 | Drooling (HP:0002307) | 1.80212011 |
| 140 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.79535274 |
| 141 | Muscle fibrillation (HP:0010546) | 1.78747487 |
| 142 | Absent/shortened dynein arms (HP:0200106) | 1.78595820 |
| 143 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.78595820 |
| 144 | Abnormal drinking behavior (HP:0030082) | 1.78180146 |
| 145 | Polydipsia (HP:0001959) | 1.78180146 |
| 146 | Absent speech (HP:0001344) | 1.76462449 |
| 147 | Hypophosphatemic rickets (HP:0004912) | 1.76109289 |
| 148 | Rhinitis (HP:0012384) | 1.76071582 |
| 149 | Inability to walk (HP:0002540) | 1.75393208 |
| 150 | Epileptiform EEG discharges (HP:0011182) | 1.75043987 |
| 151 | * Abnormality of vitamin B metabolism (HP:0004340) | 1.75029427 |
| 152 | Malnutrition (HP:0004395) | 1.74430541 |
| 153 | Keratoconjunctivitis (HP:0001096) | 1.73290046 |
| 154 | Abnormality of magnesium homeostasis (HP:0004921) | 1.72701007 |
| 155 | Focal dystonia (HP:0004373) | 1.72432687 |
| 156 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.72389502 |
| 157 | Gait ataxia (HP:0002066) | 1.71693424 |
| 158 | Loss of speech (HP:0002371) | 1.71269085 |
| 159 | Impaired vibratory sensation (HP:0002495) | 1.70542728 |
| 160 | Orchitis (HP:0100796) | 1.69628648 |
| 161 | Urinary urgency (HP:0000012) | 1.69396350 |
| 162 | Recurrent abscess formation (HP:0002722) | 1.69368020 |
| 163 | Xanthomatosis (HP:0000991) | 1.68923586 |
| 164 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.68156252 |
| 165 | Abnormality of glycolipid metabolism (HP:0010969) | 1.68156252 |
| 166 | Abnormal biliary tract physiology (HP:0012439) | 1.68029991 |
| 167 | Bile duct proliferation (HP:0001408) | 1.68029991 |
| 168 | Abnormality of renin-angiotensin system (HP:0000847) | 1.66510700 |
| 169 | Irritability (HP:0000737) | 1.65643448 |
| 170 | Myositis (HP:0100614) | 1.65228947 |
| 171 | Recurrent skin infections (HP:0001581) | 1.64702152 |
| 172 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.64206678 |
| 173 | Brushfield spots (HP:0001088) | 1.64115877 |
| 174 | Progressive macrocephaly (HP:0004481) | 1.64068091 |
| 175 | Retinal atrophy (HP:0001105) | 1.63959734 |
| 176 | Joint swelling (HP:0001386) | 1.63541055 |
| 177 | Enlarged penis (HP:0000040) | 1.63114489 |
| 178 | Vascular calcification (HP:0004934) | 1.62477480 |
| 179 | Hyperactive renin-angiotensin system (HP:0000841) | 1.61849150 |
| 180 | Epidermoid cyst (HP:0200040) | 1.61029412 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.65315238 |
| 2 | CASK | 3.77753570 |
| 3 | EPHA4 | 2.92624039 |
| 4 | TNIK | 2.83923043 |
| 5 | NTRK3 | 2.82247010 |
| 6 | STK39 | 2.63700752 |
| 7 | OXSR1 | 2.62783750 |
| 8 | MAP2K7 | 2.41888679 |
| 9 | TXK | 2.35636240 |
| 10 | PRPF4B | 2.27412191 |
| 11 | RIPK4 | 2.23935007 |
| 12 | ACVR1B | 2.16978209 |
| 13 | MAP4K2 | 2.05775851 |
| 14 | WNK3 | 2.03883643 |
| 15 | MAP3K4 | 1.82643525 |
| 16 | DAPK2 | 1.79022149 |
| 17 | TAOK3 | 1.76725504 |
| 18 | NTRK1 | 1.65455126 |
| 19 | SGK494 | 1.64021928 |
| 20 | SGK223 | 1.64021928 |
| 21 | CDK19 | 1.62169936 |
| 22 | EPHA3 | 1.60706155 |
| 23 | MUSK | 1.50859796 |
| 24 | MAP3K9 | 1.49453689 |
| 25 | STK24 | 1.47819522 |
| 26 | CAMKK2 | 1.46770541 |
| 27 | ERBB3 | 1.42268866 |
| 28 | MARK1 | 1.41556413 |
| 29 | NTRK2 | 1.41019958 |
| 30 | MAP2K4 | 1.40183416 |
| 31 | MINK1 | 1.39928246 |
| 32 | FES | 1.39621397 |
| 33 | MAP3K12 | 1.37821916 |
| 34 | PKN1 | 1.35891189 |
| 35 | MAPKAPK5 | 1.35718386 |
| 36 | TYK2 | 1.35591391 |
| 37 | BMPR2 | 1.34398502 |
| 38 | PAK6 | 1.29055092 |
| 39 | BLK | 1.28040941 |
| 40 | PASK | 1.27991143 |
| 41 | CAMK2B | 1.25333948 |
| 42 | ARAF | 1.25169194 |
| 43 | NEK6 | 1.24719551 |
| 44 | CDK5 | 1.20485189 |
| 45 | JAK1 | 1.18725330 |
| 46 | EPHB1 | 1.16806109 |
| 47 | PINK1 | 1.14337930 |
| 48 | WNK1 | 1.14163138 |
| 49 | WNK4 | 1.12083404 |
| 50 | CAMKK1 | 1.11407679 |
| 51 | INSRR | 1.10614347 |
| 52 | CAMK2A | 1.10601852 |
| 53 | FER | 1.08971672 |
| 54 | TRIM28 | 1.07603743 |
| 55 | FGFR3 | 1.06363008 |
| 56 | GRK5 | 1.06072049 |
| 57 | SGK2 | 1.03732035 |
| 58 | MAP3K13 | 1.03420424 |
| 59 | UHMK1 | 1.03038556 |
| 60 | MAPK13 | 1.02150217 |
| 61 | ITK | 1.01507963 |
| 62 | PHKG1 | 1.00669480 |
| 63 | PHKG2 | 1.00669480 |
| 64 | YES1 | 0.98936348 |
| 65 | CSK | 0.97121141 |
| 66 | PBK | 0.95957717 |
| 67 | FGR | 0.94340560 |
| 68 | PLK2 | 0.93898063 |
| 69 | IKBKE | 0.93085379 |
| 70 | PRKCE | 0.91689614 |
| 71 | CAMK2D | 0.91575763 |
| 72 | PRKCH | 0.90899696 |
| 73 | PRKCG | 0.90769000 |
| 74 | CAMK2G | 0.89005444 |
| 75 | BMPR1B | 0.85559887 |
| 76 | BCR | 0.84677537 |
| 77 | CSNK1G2 | 0.84294002 |
| 78 | GRK7 | 0.82962975 |
| 79 | MAP3K2 | 0.82700673 |
| 80 | PRKD3 | 0.81133422 |
| 81 | PDPK1 | 0.80356534 |
| 82 | IRAK2 | 0.80252358 |
| 83 | KSR2 | 0.78830281 |
| 84 | STK38L | 0.75823885 |
| 85 | STK38 | 0.75761416 |
| 86 | SYK | 0.75044751 |
| 87 | LYN | 0.73582902 |
| 88 | CAMK1 | 0.72756957 |
| 89 | GRK6 | 0.72195833 |
| 90 | SGK3 | 0.70747917 |
| 91 | PRKCQ | 0.70485494 |
| 92 | FGFR2 | 0.68940150 |
| 93 | IKBKB | 0.68123125 |
| 94 | JAK2 | 0.66273919 |
| 95 | MAP3K1 | 0.65458968 |
| 96 | CSNK1G1 | 0.64093818 |
| 97 | CSF1R | 0.63915442 |
| 98 | SGK1 | 0.63019345 |
| 99 | PDK1 | 0.61514869 |
| 100 | DYRK1A | 0.60490402 |
| 101 | TEC | 0.59269547 |
| 102 | ROCK2 | 0.58639794 |
| 103 | CSNK1G3 | 0.58628293 |
| 104 | HCK | 0.58331213 |
| 105 | STK11 | 0.57512223 |
| 106 | TRPM7 | 0.57406748 |
| 107 | PRKAA2 | 0.57163902 |
| 108 | ADRBK2 | 0.57111997 |
| 109 | CSNK1A1L | 0.57026874 |
| 110 | PRKD2 | 0.56891380 |
| 111 | MAP2K6 | 0.55941091 |
| 112 | TGFBR2 | 0.55890593 |
| 113 | LMTK2 | 0.54298111 |
| 114 | PAK3 | 0.53305948 |
| 115 | MAPK12 | 0.53199125 |
| 116 | FYN | 0.52363130 |
| 117 | CDK14 | 0.50705226 |
| 118 | MAP3K5 | 0.49856177 |
| 119 | PNCK | 0.49031275 |
| 120 | EIF2AK3 | 0.48177322 |
| 121 | MAP3K14 | 0.47840700 |
| 122 | IRAK1 | 0.47663789 |
| 123 | MAP4K1 | 0.47505190 |
| 124 | PIK3CG | 0.47434414 |
| 125 | MAPK7 | 0.46805566 |
| 126 | MARK2 | 0.46046967 |
| 127 | PDK2 | 0.45790627 |
| 128 | MST4 | 0.45721770 |
| 129 | ZAP70 | 0.45419894 |
| 130 | IRAK4 | 0.45364111 |
| 131 | SIK3 | 0.45082023 |
| 132 | CDK15 | 0.44862260 |
| 133 | NLK | 0.44822425 |
| 134 | PTK2B | 0.44817767 |
| 135 | PRKG1 | 0.44233076 |
| 136 | CDK18 | 0.43826587 |
| 137 | CSNK1A1 | 0.43353542 |
| 138 | BTK | 0.43331386 |
| 139 | GRK1 | 0.42571004 |
| 140 | TNK2 | 0.42457627 |
| 141 | AKT3 | 0.41618646 |
| 142 | PRKACA | 0.41073029 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.69076800 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.84905504 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.54573328 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.27498739 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.25457707 |
| 6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.12623745 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.10211301 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 1.97982756 |
| 9 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.97071262 |
| 10 | Protein export_Homo sapiens_hsa03060 | 1.88360203 |
| 11 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.85956514 |
| 12 | Circadian entrainment_Homo sapiens_hsa04713 | 1.85005173 |
| 13 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.75896937 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 1.69802352 |
| 15 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.67226374 |
| 16 | Olfactory transduction_Homo sapiens_hsa04740 | 1.66534301 |
| 17 | Circadian rhythm_Homo sapiens_hsa04710 | 1.65348896 |
| 18 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.59886100 |
| 19 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.52802923 |
| 20 | Long-term potentiation_Homo sapiens_hsa04720 | 1.52297860 |
| 21 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.51959220 |
| 22 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.45357544 |
| 23 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.43525571 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.43488464 |
| 25 | Long-term depression_Homo sapiens_hsa04730 | 1.39395987 |
| 26 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.38872120 |
| 27 | Insulin secretion_Homo sapiens_hsa04911 | 1.38655553 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.37221831 |
| 29 | Taste transduction_Homo sapiens_hsa04742 | 1.36603961 |
| 30 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.33300553 |
| 31 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.31833525 |
| 32 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.27623498 |
| 33 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.26587845 |
| 34 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.22703484 |
| 35 | Cocaine addiction_Homo sapiens_hsa05030 | 1.22264461 |
| 36 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.20587407 |
| 37 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.18646389 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.18565781 |
| 39 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.17903460 |
| 40 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.17870926 |
| 41 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.15731097 |
| 42 | Renin secretion_Homo sapiens_hsa04924 | 1.15456339 |
| 43 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.13855509 |
| 44 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.12874359 |
| 45 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.10733620 |
| 46 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.09227251 |
| 47 | Allograft rejection_Homo sapiens_hsa05330 | 1.08667175 |
| 48 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.07965749 |
| 49 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.06944322 |
| 50 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.06463850 |
| 51 | Retinol metabolism_Homo sapiens_hsa00830 | 1.05902188 |
| 52 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.01851472 |
| 53 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.01041973 |
| 54 | Phototransduction_Homo sapiens_hsa04744 | 1.00579633 |
| 55 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.00367492 |
| 56 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.95474956 |
| 57 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.94725642 |
| 58 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.93694868 |
| 59 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.91914175 |
| 60 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.90382846 |
| 61 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.87910520 |
| 62 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.87628309 |
| 63 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.85890443 |
| 64 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.85666530 |
| 65 | Histidine metabolism_Homo sapiens_hsa00340 | 0.85326316 |
| 66 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.85159575 |
| 67 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.85012027 |
| 68 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.84513509 |
| 69 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.82392952 |
| 70 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.81320435 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.81251792 |
| 72 | Bile secretion_Homo sapiens_hsa04976 | 0.80396243 |
| 73 | Lysosome_Homo sapiens_hsa04142 | 0.80003094 |
| 74 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.79923103 |
| 75 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.79004552 |
| 76 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.78632715 |
| 77 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.76599642 |
| 78 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.75689101 |
| 79 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.73999273 |
| 80 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.73886403 |
| 81 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.73805496 |
| 82 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.71648533 |
| 83 | Axon guidance_Homo sapiens_hsa04360 | 0.71516499 |
| 84 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.70878033 |
| 85 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.67227778 |
| 86 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.66200966 |
| 87 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.65812503 |
| 88 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.65436641 |
| 89 | Asthma_Homo sapiens_hsa05310 | 0.64126924 |
| 90 | Phagosome_Homo sapiens_hsa04145 | 0.63506360 |
| 91 | Alzheimers disease_Homo sapiens_hsa05010 | 0.62843706 |
| 92 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.62776724 |
| 93 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.62440952 |
| 94 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.62412927 |
| 95 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.62353836 |
| 96 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.61928068 |
| 97 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.61666564 |
| 98 | Gap junction_Homo sapiens_hsa04540 | 0.61525932 |
| 99 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.61257790 |
| 100 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.61197152 |
| 101 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.61031808 |
| 102 | Peroxisome_Homo sapiens_hsa04146 | 0.58493338 |
| 103 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58327316 |
| 104 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.57804837 |
| 105 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57649757 |
| 106 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.56823194 |
| 107 | Tuberculosis_Homo sapiens_hsa05152 | 0.56228735 |
| 108 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.55579477 |
| 109 | Mineral absorption_Homo sapiens_hsa04978 | 0.55556650 |
| 110 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.53606004 |
| 111 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.53039423 |
| 112 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.51889038 |
| 113 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.51687477 |
| 114 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51359088 |
| 115 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.51155227 |
| 116 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.50448633 |
| 117 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.50240060 |
| 118 | Prion diseases_Homo sapiens_hsa05020 | 0.50048992 |
| 119 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.49860768 |
| 120 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.49624850 |
| 121 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.49337644 |
| 122 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.49135841 |
| 123 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.48623212 |
| 124 | Parkinsons disease_Homo sapiens_hsa05012 | 0.48440182 |
| 125 | ABC transporters_Homo sapiens_hsa02010 | 0.47350588 |
| 126 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.47178015 |
| 127 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.46918970 |
| 128 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.46830079 |
| 129 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.46733653 |
| 130 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.46208103 |
| 131 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.44022264 |
| 132 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.43380691 |
| 133 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.43278013 |
| 134 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.42491943 |
| 135 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.42094325 |
| 136 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.41441501 |
| 137 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.40955310 |

